Krilogy Financial LLC Invests $813,000 in Agilent Technologies, Inc. $A

Krilogy Financial LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 6,332 shares of the medical research company’s stock, valued at approximately $813,000.

Other large investors have also recently added to or reduced their stakes in the company. Capital A Wealth Management LLC raised its position in Agilent Technologies by 10,600.0% in the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock worth $25,000 after purchasing an additional 212 shares during the last quarter. Davis Capital Management bought a new position in Agilent Technologies during the 3rd quarter worth approximately $28,000. Physician Wealth Advisors Inc. grew its holdings in Agilent Technologies by 490.0% during the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 196 shares during the period. State of Wyoming bought a new stake in Agilent Technologies in the second quarter valued at approximately $35,000. Finally, SJS Investment Consulting Inc. raised its stake in Agilent Technologies by 2,836.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after buying an additional 312 shares during the period.

Wall Street Analyst Weigh In

A has been the topic of a number of research reports. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their price objective for the stock from $155.00 to $160.00 in a research report on Monday, January 5th. Wells Fargo & Company boosted their target price on Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. HSBC initiated coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price target on the stock. Weiss Ratings reiterated a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Finally, Citigroup lifted their price target on shares of Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $164.50.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 911 shares of the business’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the transaction, the chief executive officer directly owned 32,058 shares in the company, valued at $4,591,987.92. The trade was a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the sale, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The disclosure for this sale is available in the SEC filing.

Agilent Technologies Price Performance

Agilent Technologies stock opened at $125.80 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The firm’s fifty day moving average is $137.84 and its 200 day moving average is $135.30. The company has a market cap of $35.58 billion, a price-to-earnings ratio of 27.53, a PEG ratio of 3.63 and a beta of 1.30.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same quarter last year, the firm posted $1.46 EPS. The firm’s revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s payout ratio is presently 22.32%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.